• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Rezolute, Inc. - Common Stock (NV) (NQ:RZLT)

    4.715 +0.145 (+3.17%)
    Streaming Delayed Price Updated: 3:14 PM EDT, Jun 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Rezolute, Inc. - Common Stock (NV)

    < Previous 1 2 3 4 Next >
    News headline image
    Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute to Participate in Upcoming Investor Conferences
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
    FDA encourages the Company to submit comprehensive data from sunRIZE and the ongoing open-label extension to inform next steps for the program 
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Launches Investigation into Rezolute
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    Rezolute to Participate in the Citizens Life Sciences Conference
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    RZLT SECURITIES ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    REZOLUTE INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Hagens Berman Investigating Rezolute, Inc. (RZLT) as Shares Tank 90% Amid Lead Asset Trial Failure
    From Hagens Berman
    Via Business Wire
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.